| Market Capitalization (Millions $) |
2,575 |
| Shares
Outstanding (Millions) |
53 |
| Employees |
622 |
| Revenues (TTM) (Millions $) |
251 |
| Net Income (TTM) (Millions $) |
-34 |
| Cash Flow (TTM) (Millions $) |
59 |
| Capital Exp. (TTM) (Millions $) |
9 |
Business Description
Axogen, Inc. is a company that develops and markets innovative surgical solutions for peripheral nerve injuries. The company was founded in 2002 and is headquartered in Alachua, Florida. Axogen's mission is to provide surgeons with products and techniques that will allow them to precisely repair or replace damaged peripheral nerves to restore function.
Axogen has a portfolio of products that includes nerve grafts, nerve connectors, and platforms that are designed to facilitate the surgical repair of nerves. Some of Axogen's key products include:
1. Avance Nerve Graft e a processed human nerve allograft that is used to bridge gaps in damaged peripheral nerves.
2. Axoguard Nerve Connector e a collagen scaffold for connecting two severed peripheral nerves.
3. Axotouch Two-Point Discriminator e a handheld device for testing the sensitivity of nerves.
In addition to its product portfolio, Axogen is also focused on developing new technologies and techniques for nerve repair. The company has an active research and development program and partners with leading academic and clinical institutions to advance the field of peripheral nerve repair.
Axogen's products are used in a variety of surgical procedures, including reconstruction after trauma or tumor removal, as well as in the treatment of chronic conditions such as carpal tunnel syndrome and diabetic neuropathy.
Axogen has a strong track record of growth and profitability, with revenues reaching $171 million in 2020. The company has a market capitalization of over $2 billion and is listed on the NASDAQ Global Select Market.
Overall, Axogen is a leading company in the field of peripheral nerve repair and has established itself as a key player in this growing market. Its innovative products and commitment to research and development make it well-positioned for continued success in the coming years.
Company Address: 13631 Progress Blvd Zagreb 32615 City of Zagreb
Company Phone Number: 462-6800 Stock Exchange / Ticker: NASDAQ AXGN
|
3.22% 
185.19 %